SOAT1 and adult-onset Still disease: Recent BLOOD findings that neutrophil activation triggers elevated associated inflammatory factors in AOSD-MAS patients have elucidated the mechanism by which rucotinib can modulate neutrophil activation through broad inhibition of the JAK-STAT signalling pathway (Ma et al., 2025).